Relationship between depression and medication adherence in cardiovascular disease: the perfect challenge for the integrated care team
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Many individuals with cardiovascular disease (CVD) experience depression that is associated with poor health outcomes, which may be because of medication nonadherence. Several factors influence medication adherence and likely influence the relationship between depression and medication adherence in CVD patients. This comprehensive study reviews the existing literature on depression and medication adherence in CVD patients, addresses the methods of and problems with measuring medication adherence, and explains why the integrated care team is uniquely situated to improve the outcomes in depressed CVD patients. This paper also explores how the team can collaboratively target depressive symptoms and medication-taking behavior in routine clinical care. Finally, it suggests the limitations to the integrated care approach, identifies targets for future research, and discusses the implications for CVD patients and their families.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous studies have found a relationship between major depressive disorder and poor adherence to cardiovascular medications. 151-155”
From Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association (2021) · cites this paper as [155]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Health outcomes may also be influenced by comorbidities such as depression, which is prevalent among individuals with cardiovascular disease.82”
From Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysis (2025) · cites this paper as [82]
In the citing paper
“Mobile phone applications may improve adherence to both medication and behavioural changes, but more evidence, particularly in patients with CVD and T2DM, is needed.378”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [378]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Scoping studies: towards a methodological framework
Arksey, H., & O'Malley, L. (2005) · International Journal of Social Research Methodology · doi:10.1080/1364557032000119616 · Cited by 36,742 · cited 1×
“Given the limited research available using objective medication adherence techniques, the researchers created this review but were informed by a scoping 51,52 rather than narrative framework.”
Scoping studies: advancing the methodology
Levac, D., Colquhoun, H., & O'Brien, K. K. (2010) · Implementation Science · doi:10.1186/1748-5908-5-69 · Cited by 15,268 · cited 1×
“Given the limited research available using objective medication adherence techniques, the researchers created this review but were informed by a scoping 51,52 rather than narrative framework.”
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Tarver, T. (2014) · Journal of Consumer Health On the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,605
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Cited by
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Levine, G. N., Cohen, B. E., Commodore-Mensah, Y., Fleury, J., Huffman, J. C., Khalid, U., Labarthe, D. R., Lavretsky, H., Michos, E. D., Spatz, E. S., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000947 · Cited by 865
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab154 · Cited by 542
Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336
[Comment] COVID-19 pandemic and its impact on mental health of healthcare professionals
Tsamakis, K., Rizos, E., Manolis, A., Chaidou, S., Kympouropoulos, S., Spartalis, E., Spandidos, D., Tsiptsios, D., & Triantafyllis, A. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8646 · Cited by 246
“Depression is associated with poor medication adherence (12) which may increase morbidity among older healthcare professionals with coexisting medical conditions.”
Physical Exercise in Major Depression: Reducing the Mortality Gap While Improving Clinical Outcomes
Belvederi Murri, M., Ekkekakis, P., Magagnoli, M., Zampogna, D., Cattedra, S., Capobianco, L., Serafini, G., Calcagno, P., Zanetidou, S., & Amore, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00762 · Cited by 163
Drapkina, O. M., Shishkova, V. M., & Kotova, M. B. (2022) · Cardiovascular Therapy and Prevention · doi:10.15829/1728-8800-2022-3438 · Cited by 160
Graham, N., Ward, J., Mackay, D., Pell, J. P., Cavanagh, J., Padmanabhan, S., & Smıth, D. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024433 · Cited by 87
Is depression the missing link between inflammatory mediators and cancer?
Polityńska, B., Pokorska, O., Wojtukiewicz, A. M., Sawicka, M., Mysliwiec, M., Honn, K. V., Tucker, S. C., & Wojtukiewicz, M. Z. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108293 · Cited by 89
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J. M., Capodanno, D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.016 · Cited by 123
Ski, C. F., Taylor, R. S., McGuigan, K., Long, L., Lambert, J. D., Richards, S. H., & Thompson, D. R. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013508.pub3 · Cited by 128
Molero, Y., Cipriani, A., Larsson, H., Lichtenstein, P., D'Onofrio, B. M., & Fazel, S. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30311-4 · Cited by 72
Gaffey, A. E., Gathright, E. C., Fletcher, L., & Goldstein, C. M. (2022) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000751 · Cited by 85
Self-citationMental Health Costs of Inflammatory Bowel Diseases
Szigethy, E., Murphy, S. M., Ehrlich, O. G., Engel-Nitz, N. M., Heller, C. A., Henrichsen, K., Lawton, R., Meadows, P., & Allen, J. I. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa030 · Cited by 55
Zhou, Y., Huo, Q., Du, S., Shi, X., Shi, Q., Cui, S., Feng, C., Du, X., & Wang, Y. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s337634 · Cited by 57
Ivanovs, R., Ķīvīte‐Urtāne, A., Ziedonis, D. M., Mintāle, I., Vrubļevska, J., & Rancāns, E. (2018) · BMC Public Health · doi:10.1186/s12889-018-5238-7 · Cited by 52
Smith, T. W. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01695-4 · Cited by 52
Lapa, M. E., Swabe, G. M., Rollman, B. L., Muldoon, M. F., Thurston, R. C., & Magnani, J. W. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.46317 · Cited by 41
Xu, H., Deng, K., Lin, Z., Huang, Z., Gong, X., Tan, J., Huang, B., & Gao, Y. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.017 · Cited by 34
A Systematic Review and Meta-Analysis of the Association Between Perceived Injustice and Depression
Lynch, J., Fox, S., D’Alton, P., & Gaynor, K. (2021) · Journal of Pain · doi:10.1016/j.jpain.2020.12.009 · Cited by 30
Pálinkás, A., Sándor, J., Papp, M., Kőrösi, L., Falusi, Z., Pál, L., Bélteczki, Z., Rihmer, Z., & Döme, P. (2018) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-018-1545-7 · Cited by 29
Вачиковна, П. Н., Boytsov, S. A., Bacquer, D. D., Sokolova, O. Y., Аушева, А. К., Kursakov, A. A., & Saner, H. E. (2021) · Global Heart · doi:10.5334/gh.1017 · Cited by 41
Lindekilde, N., Skov, O., Skovbakke, S. J., Johansen, J. B., Nielsen, J. C., & Pedersen, S. S. (2022) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2022.07.008 · Cited by 27
Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia
Alefishat, E. A., Jarab, A. S., Al-Qerem, W. A., & Abu-Zaytoun, L. (2021) · Healthcare · doi:10.3390/healthcare9070813 · Cited by 37
Rapelli, G., Donato, S., Parise, M., Pagani, A. F., Castelnuovo, G., Pietrabissa, G., Giusti, E. M., & Bertoni, A. (2022) · Health & Social Care in the Community · doi:10.1111/hsc.13704 · Cited by 29
Effect of Sacubitril-Valsartan in reducing depression in patients with advanced heart failure
Cacciatore, F., Amarelli, C., Maiello, C., Pratillo, M., Tosini, P., Mattucci, I., Salerno, G., Curcio, F., Elia, F., Mercurio, V., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.158 · Cited by 24
Disruption in time projection and non-adherence to long-term therapies
Reach, G., Boubaya, M., Brami, Y., & Lévy, V. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s180280 · Cited by 27
Behavioral Activation, Depression, and Promotion of Health Behaviors: A Scoping Review
May, D., Litvin, B., & Allegrante, J. P. (2022) · Health Education & Behavior · doi:10.1177/10901981221090157 · Cited by 28
“Other practices deleterious to overall health could manifest or worsen depression: Inadequate medication adherence within the context of chronic health problems, such as cardiovascular disease, could be linked to depression (Goldstein et al., 2017).”
BackgroundHendriks, J., Andreae, C., Ågren, S., Eriksson, H., Hjelm, C., Walfridsson, U., Ski, C. F., Thylén, I., & Jaarsma, T. (2020) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515119895734 · Cited by 21
Factors Affecting Health-Promoting Behaviors in Patients with Cardiovascular Disease
Park, H.-C., & Oh, J. (2021) · Healthcare · doi:10.3390/healthcare9010060 · Cited by 20
Bangalore, S., Shah, R., Pappadopulos, E. A., Deshpande, C. G., Shelbaya, A., Prieto, R., Stephens, J., & McIntyre, R. S. (2018) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcy023 · Cited by 20
The SPUR Model: A Framework for Considering Patient Behavior
Dolgin, K. (2020) · Patient Preference and Adherence · doi:10.2147/ppa.s237778 · Cited by 21
Wen, X., Li, Y., Zhang, Q., Yao, Z., Gao, X., Sun, Z., Fang, X., & Huang, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-95726-z · Cited by 29
“…about one-third of stroke patients will experience psychological disorders at some point in the rehabilitation process 22 , such as depression and anxiety, which will have an adverse effect on rehabilitation compliance and often lead to complications and disability, or even early death 23,24 .”
The Combined Effect of Psychological and Relational Aspects on Cardiac Patient Activation
Rapelli, G., Donato, S., Bertoni, A., Spatola, C. A. M., Pagani, A. F., Parise, M., & Castelnuovo, G. (2019) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-019-09670-y · Cited by 20
National Cross-Sectional Study of Community-Based Adverse Drug Reactions in Saudi Arabia
Almubark, R. A., Aljadani, R. H., Alqahtani, A. S., Alshammari, T. M., & BinDhim, N. F. (2020) · Drugs - Real World Outcomes · doi:10.1007/s40801-020-00186-8 · Cited by 17
Ashour, A. M., Masa’Deh, R., Hamaideh, S. H., Elshatarat, R. A., Yacoub, M. I., Almagharbeh, W. T., Alhejaili, A. A., Alshahrani, B., Sobeh, D. E., & Eltayeb, M. M. (2024) · BMC Psychology · doi:10.1186/s40359-024-01959-4 · Cited by 25
“These findings corroborate previous research highlighting the prevalence of depressive symptoms among cardiac patients and their impact on medication adherence [13, 14, 28, 48].”
BackgroundResultAdherence to Antidepressants and Mortality in Elderly Patients with Cardiovascular Disease
on behalf of the Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE), Biffi, A., Scotti, L., Rea, F., Lucenteforte, E., Chinellato, A., Vetrano, D. L., Vitale, C., Agabiti, N., Sultana, J., et al. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0642-4 · Cited by 17
Spontaneous Participation in Secondary Prevention Programs: The Role of Psychosocial Predictors
Gorini, A., Giuliani, M., Marton, G., Vergani, L., Barbieri, S., Veglia, F., & Tremoli, E. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176298 · Cited by 15
Schönenberg, A., Heimrich, K. G., & Prell, T. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05585-7 · Cited by 21
“Many authors hypothesize about potential effects of reduced concentration or motivation as a connecting factor [14, 15, 30]; however, the symptom-driven approach described above may shed light on which depressive symptoms contribute primarily to nonadherence.”
BackgroundWiegand, A., Zieger, A., Staiger, R. D., Egli, A., Freystaetter, G., Bischoff-Ferrari, H. A., & Chocano-Bedoya, P. O. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.01.013 · Cited by 15
Self-Reported Non-adherence to Medication in Japanese Patients with Cardiovascular Diseases
Suzuki, T., Shiga, T., Omori, H., Tatsumi, F., Nishimura, K., & Hagiwara, N. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0278-z · Cited by 14
Amirova, A., Taylor, L. C., Volkmer, B., Ahmed, N., Chater, A., & Fteropoulli, T. (2022) · Health Psychology Review · doi:10.1080/17437199.2022.2090411 · Cited by 16
“ment (Goldstein et al., 2017) and is an independent predictor of morbidity (Moudgil & Haddad,”
BackgroundEvaluating the role of perceived injustice in mental health outcomes in cervical cancer care
Lynch, J., D’Alton, P., & Gaynor, K. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07060-z · Cited by 11
Haller, K., Fritzsche, S., Kruse, I., O′Malley, G., Ehrenthal, J. C., & Stamm, T. J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.913081 · Cited by 13
O’Connor, A., Gill, S., Neary, E., White, S. J., & Ford, A. C. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18337 · Cited by 17
β-blocker adherence among patients with congenital long QT syndrome: a nationwide study
Krøll, J., Butt, J. H., Jensen, H. K., Fosbøl, E. L., Jespersen, C., Winkel, B. G., Kanters, J. K., Gislason, G., Torp-Pedersen, C. T., Køber, L., et al. (2022) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcac017 · Cited by 12
Zhu, L., Ferries, E., Suthoff, E. D., Namjoshi, M. A., & Bera, R. B. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.28.11-a.s1 · Cited by 19
Moreno, G., Vicent, L., Rosillo, N., Delgado, J., del Cerro, E. P., & Bueno, H. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100713 · Cited by 12
“The association of depression or depressive symptoms, both more prevalent among females [14] — with lower therapeutic adherence after AMI is well known [19,20].”
BackgroundKwek, S. Q., Yeo, T. M., Teo, J. Y. C., Seah, A. C. W., Ning, J. P. K., & Wang, W. (2025) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvaf084 · Cited by 13
The role of mental disease on the association between multimorbidity and medical expenditure
Yamanashi, H., Nobusue, K., Nonaka, F., Honda, Y., Shimizu, Y., Akabame, S., Sugimoto, T., Nagata, Y., & Maeda, T. (2020) · Family Practice · doi:10.1093/fampra/cmaa015 · Cited by 8
Adherence to Short-course Pharmacotherapy in Adults with Irritable Bowel Syndrome
Sherwin, L. B., Deroche, C. B., Krisanabud, P., Matteson, M., Bechtold, M. L., & Ruppar, T. M. (2019) · Western Journal of Nursing Research · doi:10.1177/0193945919872419 · Cited by 11
“Furthermore, as depressive symptoms improved, adherence also improved (Goldstein et al., 2017).”
BackgroundOoi, D. S. Q., Ong, S. G., Chia, J. M. X., Lim, Y. Y., Ho, C. W. L., Tay, V., Vijaya, K., Loke, K. Y., Sng, A. A., Griva, K., et al. (2023) · Pediatric Research · doi:10.1038/s41390-023-02572-8 · Cited by 9
Zmoira, A., Rogers, E., Johnson, A., & Johnson, K. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2020.12.011 · Cited by 8
Pizga, A., Kordoutis, P., Tsikrika, S., Vasileiadis, I., Nanas, S., & Karatzanos, E. (2021) · Health & Research Journal · doi:10.12681/healthresj.27572 · Cited by 13
Global research trends and mapping knowledge structure of depression in dialysis patients
Al‐Jabi, S. W. (2023) · World Journal of Psychiatry · doi:10.5498/wjp.v13.i8.593 · Cited by 12
Cheon, D. Y., Park, Y., Park, M. S., Choi, J. H., Oh, M. S., Han, S., Yu, K., Lee, B., Han, K., & Lee, M. (2024) · Journal of Internal Medicine · doi:10.1111/joim.20018 · Cited by 7
“Additionally, they may be less likely to seek medical help for cardiovascular symptoms, and depression could further reduce their motivation to seek care [42, 43].”
Psychological impact of COVID-19 pandemic on health care professionals and workers
Bashar, M., & Bammidi, R. (2020) · Industrial Psychiatry Journal · doi:10.4103/ipj.ipj_99_20 · Cited by 7
Ski, C. F., Taylor, R. S., McGuigan, K., Lambert, J. D., Richards, S. H., & Thompson, D. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013508 · Cited by 8
“MDD is also a predictor of poor disease treatment, management and medication adherence (Bauer 2012; Goldstein 2017).”
BackgroundLorem, G. F., Opdal, I. M., Wilsgaard, T., Schirmer, H., Løchen, M., Olsen, I. P., Steigen, T. K., & Rognmo, K. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-052948 · Cited by 7
Diabetes: A risk factor for poor mental health in aging population
Dey, A., Bansal, R., Chatterjee, P., Chakrawarty, A., Satpathy, S., Kumar, N. K., & Dwivedi, S. (2018) · Journal of Geriatric Mental Health · doi:10.4103/jgmh.jgmh_5_18 · Cited by 7
Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysis
Yow, D. K. W., Ang, W. J., Yap, H. J., Ito, S., Liu, J., Ko, J., Tan, D. S.-Y., Lorenzatti, A., & Ang, C.-S. (2025) · eClinicalMedicine · doi:10.1016/j.eclinm.2025.103270 · Cited by 5
“82 While 2 studies noted the presence of depression, neither explored impact on adherence outcomes or quality of life.”
The impact of magnetic resonance imaging anxiety on treatment adherence
Lei, L., Yang, X., Liu, N., Tang, L., He, X., & Huang, X. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1658226 · Cited by 7
“Poor adherence can lead to adverse consequences, such as disease progression, increased cardiovascular risk, worsening health conditions, and hindered social integration (15, 16).”
Ruksakulpiwat, S., Thongking, W., Kannan, N., Wright, E., Niyomyart, A., Benjasirisan, C., Chiaranai, C., Smothers, C. G., Aldossary, H. M., & Still, C. H. (2024) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001150 · Cited by 5
FIRST-TIME DEPRESSION IN PATIENTS WITH ACUTE CORONARY SYNDROME
Beliaevskaia, A. A., Petelin, D. S., Volel, B. A., & Ternovoy, S. K. (2022) · Russian Electronic Journal of Radiology · doi:10.21569/2222-7415-2022-12-1-89-97 · Cited by 6
Kasper, S. F. (2019) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2018.1519080 · Cited by 8
Medication Adherence in Cardiovascular Diseases
Pham, S. T., Nguyen, T. A., Tran, N. M., Le, K. K., Le, K. K., Duong, C. X., Nguyen, T. H., Taxis, K., Dang, K. D., & Nguyen, T. N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108181 · Cited by 10
Koh, Y., Segan, L. A., Crowley, R. F., Das, S. K., Lim, M. W., Maizels, L., Davey, C. G., Voskoboinik, A., Kistler, P. M., Morton, J. B., et al. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.12.010 · Cited by 4
Deo, N., Siddiqui, H., Peppercorn, K., Madani, G., Rutherford-Blyth, A., Rutledge, M. T., Williams, M. J. A., McCormick, S. P. A., & Redpath, G. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100889 · Cited by 4
Ski, C. F., Taylor, R. S., McGuigan, K., Lambert, J. D., Richards, S. H., & Thompson, D. R. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013508.pub2 · Cited by 6
McClintock, H. F. D. V., Schatell, E. T., & Bogner, H. R. (2020) · Behavioral Medicine · doi:10.1080/08964289.2020.1801570 · Cited by 4
Sherwin, L. B., Deroche, C. B., Yevu-Johnson, J., Matteson, M., Bechtold, M., Jahnke, I., & Alexander, G. L. (2021) · CIN Computers Informatics Nursing · doi:10.1097/cin.0000000000000747 · Cited by 7
Construction and application of tuberculosis medical and nursing integration cooperation model
Zhang, J., Hu, X., Ye, H., Fan, X., & Lai, D. (2022) · Public Health Nursing · doi:10.1111/phn.13135 · Cited by 4
Adherence problems in elderly patients with hypertension
Pobrotyn, P., Chudiak, A., Uchmanowicz, B., Drobnik, J., & Gajda, R. (2023) · Medical Research Journal · doi:10.5603/mrj.a2023.0004 · Cited by 9
Dhingra, R., He, F., Saunders, E. F. H., Waschbusch, D. A., Bixler, E. O., Greaney, J. L., Swigart, A. R., Al‐Shaar, L., Chinchilli, V. M., Yanosky, J. D., et al. (2023) · Psychiatry Research Communications · doi:10.1016/j.psycom.2023.100139 · Cited by 5
The Impact of Post-Myocardial Infarction (MI) Depression on Cardiovascular-Related Hospitalizations
Henderson, C., Gillard, C. J., Wheeler, J. B., Maestri, T. J., Smith, C., & Olet, S. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102070 · Cited by 9
Recurrent lower urinary tract infections: more than an infection for older women
Ganidağlı, S., Öztürk, E., & Öztürk, Z. A. (2023) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.55730/1300-0144.5706 · Cited by 5
“One recent study demonstrated that depression diminished the chemotactic function of both neutrophils and lymphocytes [49], while another determined that patients with severe depression were 3.7 times likelier to be medication nonadherent than nondepressed patients [50].”
BackgroundInfluentialВеликанов, А. А., Stoljarova, A. A., Protasov, E. A., Zelenskaya, I. A., & Игоревна, Л. Е. (2020) · Вестник Российского университета дружбы народов. Серия: Психология и педагогика · doi:10.22363/2313-1683-2020-17-2-310-329 · Cited by 6
Saleh, Z. T., Maabreh, R. S. A., Murad, A. A., Al-Za'areer, M. S., Abujaber, D. A., Subih, M. M., Almagharbeh, W. T., Sobeh, D. E., Eltayeb, M. M., & Elshatarat, R. A. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00935 · Cited by 8
Survival outcomes associated with antidepressant use in glioblastoma: a cohort study
Sun, Y., Hamo, M. A., Atchley, T. J., Markert, J. M., Nabors, B., & Estévez-Ordoñez, D. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-025-05288-3 · Cited by 3
George, M., Maurina, I., & Schutte, A. E. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03413-2 · Cited by 4
“Comorbid depression Adv Ther (2026) 43:1–19 is common in patients with CVD and can also undermine adherence [33].”
Wakob, I., Wintsche, I., Frisch, A., Remane, Y., Laufs, U., Bertsche, T., & Schiek, S. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/6585271 · Cited by 2
Bekele, B. B., Bogale, B., Negash, S., Tesfaye, M., Getachew, D., Weldekidan, F., & Yosef, T. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00878-0 · Cited by 3
Calabria, S., Andreotti, F., Ronconi, G., Dondi, L., Campeggi, A., Piccinni, C. P., Pedrini, A., Esposito, I., Addesi, A., Martini, N., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164888 · Cited by 3
Dhingra, R., He, F., Saunders, E. F. H., Waschbusch, D. A., Pearl, A. M., Bixler, E. O., Greaney, J. L., Swigart, A. R., Al‐Shaar, L., Chinchilli, V. M., et al. (2024) · Mental Illness · doi:10.1155/2024/1689172 · Cited by 5
“Furthermore, persons with mental illness tend to have poor medication compliance and management of coexisting medical conditions [42]; this may lead to greater severity of CVD conditions and use of multiple treatments.”
BackgroundGannu, L., Devine, F., Popadic, L., Lal, S., Witte, M. M., Potter, M., & Hass, S. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2348603 · Cited by 3
“Treatment of comorbid conditions can also increase the medication burden in patients which may further complicate the already difficult pharmacological management of MDD 23–26 .”
BackgroundFarah, C. L. U. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr23809044938 · Cited by 4
Yu, Y., Huang, Q., & Qin, K. (2025) · Psychology Health & Medicine · doi:10.1080/13548506.2025.2478659 · Cited by 4
“Although previous studies have illustrated significant associations among ADLs, depressive symptoms, self-efficacy, and medication adherence (Goldstein et al., 2017; He et al., 2019; Iovino et al., 2023; Zhou et al., 2022), these variables were only partially explored by separate studies, and most…”
Proactive inter-disciplinary CME to improve medication management in the elderly population
Traina, S., Armando, L. G., Diarassouba, A., Parisi, R. B., Esiliato, M., Rolando, C., Remani, E., de Cosmo, P., & Cena, C. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.08.005 · Cited by 3
McGuigan, K. (2019) · Evidence-Based Nursing · doi:10.1136/ebnurs-2018-103012 · Cited by 3
Roohafza, H., Shojaei, Y., Azizian, S., Zamani, Z., Shafiei, M., Masoumi, G., & Sadeghi, M. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_155_22 · Cited by 2
“[10] However, a systematic review showed that this association between depression and patients’ compliance is still unpredictable.”
BackgroundSun, Y., Ramapuram, H., Razi, R., Hamo, M. A., Howell, S., Laskay, N. M. B., Tracz, J. A., Mahavadi, A. K., Mooney, J. H., & Godzik, J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155516 · Cited by 3
Over Depression and Mood Disorders among Sexual and Gender Minority Populations
Chodzen, G., Mays, V. M., & Cochran, S. D. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190067991.013.5 · Cited by 2
Li, Y., Liu, M., Sun, S., Lao, J., Zhao, C., Yang, Y., Wang, Q., & Tang, F. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119407 · Cited by 3
Platelet-Rich Plasma (PRP) is a Potential Self-Sourced Cognition Booster in Elderly Mice
Demir, E. A., & Karagoz, M. (2020) · Experimental Aging Research · doi:10.1080/0361073x.2020.1716154 · Cited by 3
Alizadeh, P., Bahramali, E., Hedayati, A., & Dehghan, A. (2021) · Galen Medical Journal · doi:10.31661/gmj.v10i0.1512 · Cited by 2
Murphy, B. M., Navaratnam, H. S., Grande, M. R. L., Higgins, R. O., Rogerson, M. C., Elliott, P., Worcester, M. C., & Jackson, A. C. (2022) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000753 · Cited by 5
The Social Context: Social and Behavioral Factors That Affect Health Outcomes
Hirth, J. M., González, S., & Zoorob, R. (2023) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2023.04.008 · Cited by 3
Harnessing Digital Health Solutions to Enhance Medication Adherence in Patients With Depression
Okoye, V., Okoye, G., & Appiah, D. (2024) · Innovations in Digital Health Diagnostics and Biomarkers · doi:10.36401/iddb-23-13 · Cited by 2
Sanborn, V. E., Azcárate-Peril, M. A., & Gunstad, J. (2019) · Applied Neuropsychology Adult · doi:10.1080/23279095.2019.1680987 · Cited by 5
Metadata
- Authors
- Goldstein, C. M., Gathright, E. C., & Garcia, S.
- Affiliations
- Brown University (US)
- Kent State University (US)
- University of Michigan (US)
- Corresponding author
- Goldstein, Carly M
- Venue
- Patient Preference and Adherence
- Publisher
- Informa UK Limited
- Published
- 2017-03
- Volume
- Volume 11
- Pages
- 547-559
- ISSN
- 1177-889X (ISSN-L)
- PMC
- PMC5359120
- OpenAlex
- W2607494643
- Cited by
- 138
- References
- 91
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 16 · 2023: 17 · 2022: 23 · 2021: 15 · 2020: 21 · 2019: 12 · 2018: 7
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Patient Preference and Adherence (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- depression, medication adherence, cardiovascular disease, integrated care teams, medication adherence measurement, depressive symptoms, medication-taking behavior, collaborative care, family caregivers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
